Literature DB >> 26370338

Cancer risk in the transgender community.

.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26370338     DOI： 10.1016/S1470-2045(15)00249-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  7 in total

1.  Survey of Principal Investigators in Biobanking: Knowledge, Attitudes, and Research Behaviors About Transgender and Gender-Diverse Patients.

Authors:  Nat C Jones; Monica E Reyes; Gwendolyn P Quinn; Matthew B Schabath
Journal:  JCO Oncol Pract       Date:  2020-06-11

2.  Frequency and distribution of primary site among gender minority cancer patients: An analysis of U.S. national surveillance data.

Authors:  Rebecca Nash; Kevin C Ward; Ahmedin Jemal; David E Sandberg; Vin Tangpricha; Michael Goodman
Journal:  Cancer Epidemiol       Date:  2018-03-09       Impact factor: 2.984

Review 3.  Cancer in Transgender People: Evidence and Methodological Considerations.

Authors:  Hayley Braun; Rebecca Nash; Vin Tangpricha; Janice Brockman; Kevin Ward; Michael Goodman
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

4.  Assessing the Quality of Care Delivered to Transgender and Gender Diverse Patients with Cancer in Ireland: A Case Series.

Authors:  Carolyn Moloney; Margaret Allen; Derek G Power; Richard M Bambury; Deirdre O'Mahony; Dearbhaile M O'Donnell; Seamus O'Reilly; Dearbhaile C Collins
Journal:  Oncologist       Date:  2020-12-19

5.  Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States.

Authors:  Sarah S Jackson; Xuesong Han; Ziling Mao; Leticia Nogueira; Gita Suneja; Ahmedin Jemal; Meredith S Shiels
Journal:  J Natl Cancer Inst       Date:  2021-09-04       Impact factor: 11.816

6.  LGBTQI cancer patients' quality of life and distress: A comparison by gender, sexuality, age, cancer type and geographical remoteness.

Authors:  Jane M Ussher; Kimberley Allison; Janette Perz; Rosalie Power
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

Review 7.  Gender and sex disparity in cancer trials.

Authors:  Eudocia Lee; Patrick Wen
Journal:  ESMO Open       Date:  2020-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.